Although most cases of Chiari malformation type I (CM1) are sporadic, familial cases of CM1, with or without syringomyelia, suggest a genetic cause in the pathogenesis of these malformations. The hypothesis is that there is one or more genes, in particular among those involved in the development of the axial skeleton and the cranium, which could lead to an abnormal morphology of the posterior fossa resulting in tonsillar herniation defining CM1. The abnormal circulation of cerebrospinal fluid due to tonsillar herniation is believed to be responsible, in some patients whose predisposing factors remain to be determined, for the progressive onset of associated syringomyelia. Since the determinants underlying the development of the posterior fossa of the skull are multigenic, the analysis of familial cases would make it possible to reduce genetic and phenotypic heterogeneity allowing to identify common pathogenic variants. For this study the investigators will be taking a blood sample to perform whole exome sequencing, build a biological collection and record imaging and clinical data.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
40
clinical-radiological evaluation, genetic analysis by whole exome sequencing and constitution of a bio-collection
Service de Neurochirurgie
Le Kremlin-Bicêtre, Kremlin-Bicêtre, France
Identification of the gene (s) whose mutations are responsible for the occurrence of a Chiari type I malformation, whether associated with syringomyelia or not.
Description of gene mutations in patients with Chiari type I malformation by whole exome sequencing
Time frame: At inclusion (as soon as the patient agree)
Identification of the gene (s) whose mutations are associated with the occurrence of syringomyelia in patients with Chiari type I malformation
Description of gene mutations in patients with syringomyelia associated with Chiari type I malformation
Time frame: At inclusion (as soon as the patient agree)
Establishment of a DNA bank for familial Chiari type I malformations
Bio-collection
Time frame: At inclusion (as soon as the patient agree)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.